Page last updated: 2024-10-29

ketoconazole and Dermatitis, Exfoliative

ketoconazole has been researched along with Dermatitis, Exfoliative in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Dermatitis, Exfoliative: The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rand, R1
Sober, AJ1
Olmstead, PM1

Other Studies

1 other study available for ketoconazole and Dermatitis, Exfoliative

ArticleYear
Ketoconazole therapy and exfoliative erythroderma.
    Archives of dermatology, 1983, Volume: 119, Issue:2

    Topics: Candidiasis; Dermatitis, Exfoliative; Drug Eruptions; Graft Rejection; Humans; Imidazoles; Ketoconaz

1983